Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 3Gastrointestinal 3Other solid neoplasm 2Genitourinary 2Breast 2Sarcoma 1Other hematologic neoplasm 1Other 1Lymphoid 1Endocrine 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 2Breast Neoplasms 1Anxiety Disorders 1

Interventions

Docetaxel 409pembrolizumab 332Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Aromatherapy × Genitourinary × Clear all
NCT05012813 2026-03-09

Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer

OHSU Knight Cancer Institute

Phase NA Completed
28 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT06119438 2023-11-07

Aromatherapy on Pain and Anxiety of the Patients Undergoing Prostate Biopsy

Mersin Training and Research Hospital

Phase NA Completed
120 enrolled
Genitourinary

Anxiety Disorders, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡